메뉴 건너뛰기




Volumn 62, Issue 7, 2016, Pages 982-992

Growth differentiation factor 15, its 12-month relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA study

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; TROPONIN T; GDF15 PROTEIN, HUMAN;

EID: 84976488771     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.254755     Document Type: Article
Times cited : (31)

References (30)
  • 1
    • 77951927068 scopus 로고    scopus 로고
    • WHO Nr. 317 January Accessed May 2016
    • WHO. Cardiovascular diseases: Fact sheet Nr. 317 January 2015. http://www.who.int/mediacentre/factsheets/fs317/en/(Accessed May 2016).
    • (2015) Cardiovascular Diseases: Fact Sheet
  • 2
    • 84855353573 scopus 로고    scopus 로고
    • Heart disease and stroke statistics- 2012 update: A report from the American Heart Association
    • Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics- 2012 update: A report from the American Heart Association. Circulation 2012;125: E2-e220.
    • (2012) Circulation , vol.125 , pp. e2-e220
    • Roger, V.L.1    Go, A.S.2    Lloyd-Jones, D.M.3    Benjamin, E.J.4    Berry, J.D.5    Borden, W.B.6
  • 3
    • 84887113261 scopus 로고    scopus 로고
    • The story of growth differentiation factor 15: Another piece of the puzzle
    • Lindahl B. The story of growth differentiation factor 15: Another piece of the puzzle. Clin Chem 2013;59: 1550-2.
    • (2013) Clin Chem , vol.59 , pp. 1550-1552
    • Lindahl, B.1
  • 4
    • 84883809336 scopus 로고    scopus 로고
    • The multiple facets of the TGF-beta family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
    • Unsicker K, Spittau B, Krieglstein K. The multiple facets of the TGF-beta family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1. Cytokine Growth Factor Rev 2013;24: 373-84.
    • (2013) Cytokine Growth Factor Rev , vol.24 , pp. 373-384
    • Unsicker, K.1    Spittau, B.2    Krieglstein, K.3
  • 5
    • 33646076691 scopus 로고    scopus 로고
    • The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
    • Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98: 351-60.
    • (2006) Circ Res , vol.98 , pp. 351-360
    • Kempf, T.1    Eden, M.2    Strelau, J.3    Naguib, M.4    Willenbockel, C.5    Tongers, J.6
  • 6
    • 8644230017 scopus 로고    scopus 로고
    • Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions
    • Schlittenhardt D, Schober A, Strelau J, Bonaterra GA, Schmiedt W, Unsicker K, et al. Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. Cell Tissue Res 2004;318: 325-33.
    • (2004) Cell Tissue Res , vol.318 , pp. 325-333
    • Schlittenhardt, D.1    Schober, A.2    Strelau, J.3    Bonaterra, G.A.4    Schmiedt, W.5    Unsicker, K.6
  • 7
    • 77958507769 scopus 로고    scopus 로고
    • Serial measurement of growthdifferentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial
    • Anand IS, Kempf T, Rector TS, Tapken H, Allhoff T, Jantzen F, et al. Serial measurement of growthdifferentiation factor-15 in heart failure: Relation to disease severity and prognosis in the Valsartan Heart Failure Trial. Circulation 2010;122: 1387-95.
    • (2010) Circulation , vol.122 , pp. 1387-1395
    • Anand, I.S.1    Kempf, T.2    Rector, T.S.3    Tapken, H.4    Allhoff, T.5    Jantzen, F.6
  • 9
    • 84964789176 scopus 로고    scopus 로고
    • Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: Results from the PLATO study. Published ahead of print
    • Hagstrom E, James SK, Bertilsson M, Becker RC, Himmelmann A, Husted S, et al. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: Results from the PLATO study. Published ahead of print. Eur Heart J 2015;37: 1325-33.
    • (2015) Eur Heart J , vol.37 , pp. 1325-1333
    • Hagstrom, E.1    James, S.K.2    Bertilsson, M.3    Becker, R.C.4    Himmelmann, A.5    Husted, S.6
  • 10
    • 36849078690 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
    • Kempf T, Bjorklund E, Olofsson S, Lindahl B, Allhoff T, Peter T, et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 2007;28: 2858-65.
    • (2007) Eur Heart J , vol.28 , pp. 2858-2865
    • Kempf, T.1    Bjorklund, E.2    Olofsson, S.3    Lindahl, B.4    Allhoff, T.5    Peter, T.6
  • 11
    • 33847324324 scopus 로고    scopus 로고
    • Circulating concentrations of growthdifferentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay
    • Kempf T, Horn-Wichmann R, Brabant G, Peter T, Allhoff T, Klein G, et al. Circulating concentrations of growthdifferentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin Chem 2007;53: 284-91.
    • (2007) Clin Chem , vol.53 , pp. 284-291
    • Kempf, T.1    Horn-Wichmann, R.2    Brabant, G.3    Peter, T.4    Allhoff, T.5    Klein, G.6
  • 12
    • 70349679012 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: Results from the AtheroGene study
    • Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS, et al. Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: Results from the AtheroGene study. Circ Cardiovasc Genet 2009;2: 286-92.
    • (2009) Circ Cardiovasc Genet , vol.2 , pp. 286-292
    • Kempf, T.1    Sinning, J.M.2    Quint, A.3    Bickel, C.4    Sinning, C.5    Wild, P.S.6
  • 13
    • 34848820630 scopus 로고    scopus 로고
    • Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome
    • Wollert KC, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Allhoff T, Peter T, et al. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007;116: 1540-8.
    • (2007) Circulation , vol.116 , pp. 1540-1548
    • Wollert, K.C.1    Kempf, T.2    Lagerqvist, B.3    Lindahl, B.4    Olofsson, S.5    Allhoff, T.6    Peter, T.7
  • 14
    • 70349652501 scopus 로고    scopus 로고
    • Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure
    • Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Gut S et al. Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure. Basic Res Cardiol 2009; 104: 731-8.
    • (2009) Basic Res Cardiol , vol.104 , pp. 731-738
    • Frankenstein, L.1    Remppis, A.2    Frankenstein, J.3    Hess, G.4    Zdunek, D.5    Gut, S.6
  • 15
    • 33646076196 scopus 로고    scopus 로고
    • GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation
    • Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;98: 342-50.
    • (2006) Circ Res , vol.98 , pp. 342-350
    • Xu, J.1    Kimball, T.R.2    Lorenz, J.N.3    Brown, D.A.4    Bauskin, A.R.5    Klevitsky, R.6
  • 16
    • 78649658074 scopus 로고    scopus 로고
    • The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
    • Stahrenberg R, Edelmann F,MendeM, Kockskamper A, Dungen HD, Luers C, et al. The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction. Eur J Heart Fail 2010;12: 1309-16.
    • (2010) Eur J Heart Fail , vol.12 , pp. 1309-1316
    • Stahrenberg, R.1    Edelmann, F.2    Mende, M.3    Kockskamper, A.4    Dungen, H.D.5    Luers, C.6
  • 17
    • 84856030536 scopus 로고    scopus 로고
    • Relations of growthdifferentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects
    • Eggers KM, Kempf T, Lind L, Sundstrom J, Wallentin L, Wollert KC, Siegbahn A. Relations of growthdifferentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects. Scand J Clin Lab Invest 2012;72: 45-51.
    • (2012) Scand J Clin Lab Invest , vol.72 , pp. 45-51
    • Eggers, K.M.1    Kempf, T.2    Lind, L.3    Sundstrom, J.4    Wallentin, L.5    Wollert, K.C.6    Siegbahn, A.7
  • 18
    • 70349662162 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: Results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study
    • Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: Results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Eur Heart J 2009;30: 2346-53.
    • (2009) Eur Heart J , vol.30 , pp. 2346-2353
    • Lind, L.1    Wallentin, L.2    Kempf, T.3    Tapken, H.4    Quint, A.5    Lindahl, B.6
  • 19
    • 33847284450 scopus 로고    scopus 로고
    • Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
    • Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, et al. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007;115: 962-71.
    • (2007) Circulation , vol.115 , pp. 962-971
    • Wollert, K.C.1    Kempf, T.2    Peter, T.3    Olofsson, S.4    James, S.5    Johnston, N.6
  • 20
    • 34548042300 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 in cardiovascular disease: From bench to bedside, and back
    • Wollert KC. Growth-differentiation factor-15 in cardiovascular disease: From bench to bedside, and back. Basic Res Cardiol 2007;102: 412-5.
    • (2007) Basic Res Cardiol , vol.102 , pp. 412-415
    • Wollert, K.C.1
  • 21
    • 84885308886 scopus 로고    scopus 로고
    • A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
    • Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, et al. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure. Int J Cardiol 2013;168: 1251-7.
    • (2013) Int J Cardiol , vol.168 , pp. 1251-1257
    • Richter, B.1    Koller, L.2    Hohensinner, P.J.3    Zorn, G.4    Brekalo, M.5    Berger, R.6
  • 22
    • 84922480777 scopus 로고    scopus 로고
    • Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (Aristotle) trial
    • Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, et al. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 2014;130: 1847-58.
    • (2014) Circulation , vol.130 , pp. 1847-1858
    • Wallentin, L.1    Hijazi, Z.2    Andersson, U.3    Alexander, J.H.4    De Caterina, R.5    Hanna, M.6
  • 23
    • 79957496852 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: The Rancho Bernardo Study
    • Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett- Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: The Rancho Bernardo Study. Circulation 2011;123: 2101-10.
    • (2011) Circulation , vol.123 , pp. 2101-2110
    • Daniels, L.B.1    Clopton, P.2    Laughlin, G.A.3    Maisel, A.S.4    Barrett-Connor, E.5
  • 24
    • 84863393862 scopus 로고    scopus 로고
    • Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: Observations from the Dallas Heart Study
    • Rohatgi A, Patel P, Das SR, Ayers CR, Khera A, Martinez- Rumayor A, et al. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: Observations from the Dallas Heart Study. Clin Chem 2012;58: 172-82.
    • (2012) Clin Chem , vol.58 , pp. 172-182
    • Rohatgi, A.1    Patel, P.2    Das, S.R.3    Ayers, C.R.4    Khera, A.5    Martinez-Rumayor, A.6
  • 25
    • 84862907513 scopus 로고    scopus 로고
    • Growth differentiation factor 15: A canary in a coal mine?
    • Ho JE, Wang TJ. Growth differentiation factor 15: A canary in a coal mine? Clin Chem 2011;58: 3-5.
    • (2011) Clin Chem , vol.58 , pp. 3-5
    • Ho, J.E.1    Wang, T.J.2
  • 26
    • 78650860293 scopus 로고    scopus 로고
    • Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: Observations from PROVE ITTIMI 22
    • Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S, et al. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: Observations from PROVE ITTIMI 22. Arterioscler Thromb Vasc Biol 2011;31: 203-10.
    • (2011) Arterioscler Thromb Vasc Biol , vol.31 , pp. 203-210
    • Bonaca, M.P.1    Morrow, D.A.2    Braunwald, E.3    Cannon, C.P.4    Jiang, S.5    Breher, S.6
  • 27
    • 65949104299 scopus 로고    scopus 로고
    • Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
    • Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 2009;30: 1057-65.
    • (2009) Eur Heart J , vol.30 , pp. 1057-1065
    • Khan, S.Q.1    Ng, K.2    Dhillon, O.3    Kelly, D.4    Quinn, P.5    Squire, I.B.6
  • 29
    • 77952536044 scopus 로고    scopus 로고
    • Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome
    • Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, et al. Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circ Cardiovasc Genet 2010;3: 88-96.
    • (2010) Circ Cardiovasc Genet , vol.3 , pp. 88-96
    • Eggers, K.M.1    Kempf, T.2    Lagerqvist, B.3    Lindahl, B.4    Olofsson, S.5    Jantzen, F.6
  • 30
    • 84879726788 scopus 로고    scopus 로고
    • Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals
    • Eggers KM, Kempf T, Wallentin L, Wollert KC, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin Chem 2013;59: 1091-8.
    • (2013) Clin Chem , vol.59 , pp. 1091-1098
    • Eggers, K.M.1    Kempf, T.2    Wallentin, L.3    Wollert, K.C.4    Lind, L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.